The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

TLX FINANCIAL STATEMENTS

TELIX Pharmaceuticals Ltd — balance sheet, income statement and cash flow trends

TLXTELIX Pharmaceuticals Ltd

🇦🇺 Australia · AU · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
0500 M1 B2020202120222023202420252026

Profit Funnel

Q1 2026 · TTM
Revenue1.3 B $Gross Profit683.5 M $ · 52%Operating Income-9.6 M $ · -1%Pre-tax Income41 M $ · 3%Net Income to Owners49.7 M $ · 4%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue1.3 B $+178.4%
Gross Profit683.5 M $+96.5%
Operating Income-9.6 M $-128.3%
EBITDA45.2 M $-24.5%
Net Income to Owners49.7 M $+1.1%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
01 B2 B2020202120222023202420252026

Capital Structure

Q1 2026
Total Assets2 B
  • Equity703.9 M $36%
  • Current Liabilities349.8 M $18%
  • Long-term Liabilities912 M $46%

Key Figures

YoY change
Total Assets2 B $+163.5%
Total Liabilities1.3 B $+269.0%
Total Equity703.9 M $+74.2%
Cash & ST Investments363.6 M $+206.0%
Total Debt837 M $+3,383.7%
Net Debt473.4 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-100 M-50 M050 M2020202120222023202420252026

Cash Flow Bridge

Q1 2026 · TTM
-100 M-50 M050 M-21.6 M $Operating-76.3 M $Investing167.5 M $Financing69.6 M $Net Change

Key Figures

YoY change
Operating Cash Flow-21.6 M $-234.1%
Capital Expenditures67.1 M $+212.5%
Free Cash Flow-88.7 M $-489.9%
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on TLX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.